{"nct_id":"NCT02311673","title":"Phase 2 Trial to Evaluate Safety and Efficacy of Setmelanotide (RM-493) in Obese Participants With Prader-Willi Syndrome","status":"COMPLETED","status_verified_date":"2023-07","start_date":"2015-03-19","start_date_type":"ACTUAL","primary_completion_date":"2016-10-26","primary_completion_date_type":"ACTUAL","completion_date":"2016-10-26","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["RYTM"]}